Ambrx Biopharma Inc. American Depositary Shares (each representing seven) Soared

Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE) rocketted at $4.54, representing a gain of 1007.6%. On Fri, Dec 09, 2022, AMAM:NYSE touched a New 2-Week High of $4.54. The stock appeared on our News Catalysts scanner on Fri, Dec 09, 2022 at 11:19 AM in the 'BIOTECH' category. From Fri, Nov 25, 2022, the stock recorded 40.00% Up Days and 18.18% Green Days
About Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE)
Ambrx Biopharma Inc is a clinical-stage biologics company focused on discovering and developing a novel class of engineered precision biologics (EPBs) using its proprietary expanded genetic code...
Top 10 Gainers:
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 1007.59%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 117.57%
- ClearOne, Inc. (CLRO:NASDAQ), 73.4%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 53.24%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 43.41%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 40.39%
- Cardiol Therapeutics Inc. (CRDL:NASDAQ), 38.3%
- PainReform Ltd. (PRFX:NASDAQ), 37.21%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 35.97%
- Acer Therapeutics Inc. (ACER:NASDAQ), 35.67%